Silo Pharma
SILO
10 hedge funds and large institutions have $231K invested in Silo Pharma in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.
32% more capital invested
Capital invested by funds: $176K → $231K (+$55.6K)
25% more funds holding
Funds holding: 8 → 10 (+2)
0.12% more ownership
Funds ownership: 0.23% → 0.34% (+0.12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$49.6K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$19.3K |
| 3 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
+$8.32K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.2K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.77K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FAIM
1
Financial Advocates Investment Management
Olympia,
Washington
| $90.4K | +$8.32K | +367 | +10% |
|
|
2
UBS Group
Zurich,
Switzerland
| $47.3K | +$49.6K | +2,190 | New |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $23.5K | +$2.77K | +122 | +13% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $23.3K | – | – | – |
|
|
TSS
5
Two Sigma Securities
New York
| $18.4K | +$19.3K | +853 | New |
|
6
State Street
Boston,
Massachusetts
| $18K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $10.1K | +$3.2K | +141 | +43% |
|
|
WIM
8
Westside Investment Management
Santa Monica,
California
| $135 | – | – | – |
|
|
FIM
9
FWL Investment Management
Dallas,
Texas
| $115 | – | – | – |
|
10
Wells Fargo
San Francisco,
California
| $29 | – | – | – |
|
SILO Hedge Fund Activity: Q4 2023 in Review
10 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q4 2023, worth a combined $231K — up 32% from $176K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new SILO positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $49.6K.
- 10 institutional investors held Silo Pharma (SILO) as of Q4 2023, up from 8 in Q3 2023.
- Funds reported $231K of Silo Pharma stock for Q4 2023, up 32% quarter-over-quarter.
- 2 funds opened new Silo Pharma positions in Q4 2023 and 0 closed out, a net change of +2 holders.
- The largest Silo Pharma buyer in Q4 2023 was UBS Group, an estimated $49.6K added.
Based on aggregated 13F filings for Q4 2023.